Nachrichten zur Nektar Therapeutics Corp. Aktie

Nektar (NKTR) delivered earnings and revenue surprises of -22.22% and 40.47%, respectively, for the quarter ended March 2025. Do the…

Nektar (NKTR) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Nektar (NKTR) delivered earnings and revenue surprises of 215.38% and 25.23%, respectively, for the quarter ended December 2024. Do the…

Nektar Therapeutics chief R&D officer sells $48,048 in stock…

…

…

Nektar (NKTR) delivered earnings and revenue surprises of -19.05% and 36.26%, respectively, for the quarter ended June 2024. Do the…

…

Nektar Therapeutics executive sells over $12k in shares…

…

Earnings call: Nektar Therapeutics unveils drug development progress…

…

Nektar Therapeutics secures $30 million in private financing…

…